Is Abivax S.A. (ABVX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.1% / 30% | 1.7% / 30% | 0.2% / 30% | N/A | ✓ HALAL |
| DJIM | 1.1% / 33% | 1.7% / 33% | 0.2% / 33% | N/A | ✓ HALAL |
| MSCI | 47.4% / 33% | 70.3% / 33% | 7.6% / 33% | N/A | ✗ NOT HALAL |
| S&P | 1.1% / 33% | 1.7% / 33% | 0.2% / 33% | N/A | ✓ HALAL |
| FTSE | 47.4% / 33% | 70.3% / 33% | 7.6% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -3743.4% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -135.6% | |
| Return on Assets (ROA) | -39.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$154M |
| Free Cash Flow | -$155M |
| Total Debt | $97M |
| Debt-to-Equity | 7.0 |
| Current Ratio | 8.7 |
| Total Assets | $205M |
Price & Trading
| Last Close | $109.48 |
| 50-Day MA | $118.22 |
| 200-Day MA | $90.00 |
| Avg Volume | 1.2M |
| Beta | -0.4 |
|
52-Week Range
$4.77
| |
About Abivax S.A. (ABVX)
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Abivax S.A. (ABVX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Abivax S.A. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Abivax S.A.'s debt ratio?
Abivax S.A.'s debt ratio is 1.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 47.4%.
What are Abivax S.A.'s key financial metrics?
Abivax S.A. has a market capitalization of $8.1B. Return on equity stands at -135.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.